StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Chandan Taparia, Motilal Oswal

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))18 May 2026via ET Now

Entry₹1,872.8Inferred
Target₹1,960
Total upside +4.66% (call closed)
Stop loss₹1,835-2.02% risk
Exit₹1,83522 May 2026, 2:55 pm
Stop-loss hit-2.02%
Follow Chandan Taparia for new calls(30% target hit, 259 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 11:54 pm IST
1 supporting2 neutral0 opposing
Supports the BUY call (1)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·19 May · 3d ago

Neutral / worth noting (2)

Sun Pharmaceutical Industries Limited has submitted to the Exchange, the Audited Financial Results for the quarter and year ended 31 March 2026.

NSE · Outcome of Board Meeting·22 May · today

(opens in new tab)

CRISIL and ICRA have reaffirmed Sun Pharma's long-term bank facilities ratings at 'AAA' and short-term ratings at 'A1+'. CRISIL has placed the long-term rating on 'Rating Watch with Developing Implica

BSE · Company Update·7 May · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Chandan Taparia, Motilal Oswal

Every call and its outcome